美股市場個股詳情
ANIP ANI Pharmaceuticals
- 55.860
- +0.760+1.38%
收盤價 11/21 16:00 (美東)
- 55.860
- 0.0000.00%
盤後 16:12 (美東)
11.74億總市值-118851市盈率TTM
56.380最高價54.750最低價18.19萬股成交量55.600今開55.100昨收1015.66萬成交額1.13%換手率65.72市盈率(靜)2101.78萬總股本70.81052周最高2.89市淨率8.97億流通值48.20052周最低--股息TTM1605.24萬流通股392.040歷史最高--股息率TTM2.96%振幅4.800歷史最低55.831平均價1股每手
關於ANI Pharmaceuticals公司
ANI Pharmaceuticals Inc 開發、製造和銷售仿製藥。 它生產液體、粉末和口服固體劑量產品。 其產品開發領域包括麻醉劑、溶瘤劑、激素和類固醇，以及涉及緩釋和組合產品的複雜配方。 它的一些通用產品包括紅黴素琥珀酸乙酯、甲基睾酮酯化雌激素 (EEMT)、依託度酸非諾貝特、氟伏沙明、氫化可的松灌腸劑和萬古黴素。 它的地理部門是美國和加拿大，其中大部分收入來自美國。
公司介紹
公司代碼ANIP
公司名稱ANI Pharmaceuticals
上市日期2003/10/01
成立日期1996
CEOMr. Nikhil Lalwani
所屬市場納斯達克
員工數量642
年結日12-31
公司地址210 Main Street West
城市Baudette
省份明尼蘇達州
國家美國
郵編56623
電話1-218-634-3500
董事高管
- 姓名
- 職務
- 年薪
- Nikhil Lalwani
- Director, President and Chief Executive Officer
- 807.84萬
- Krista Davis
- Senior Vice President and Chief Human Resources Officer
- --
- Stephen P. Carey
- Senior Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 257.61萬
- Meredith W. Cook
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Christopher Mutz
- Senior Vice President and Head of Rare Diseases
- 191.45萬
- James G. Marken
- Senior Vice President, Operations and Product Development
- --
- Thomas Rowland
- Senior Vice President, Corporate Development & Strategy
- --
- Ori Gutwerg
- Senior Vice President, Generics
- 194.17萬
- Chad Gassert
- Senior Vice President, Corporate Development and Strategy
- 189.62萬
- Patrick D. Walsh
- Chairman of the Board
- 42.22萬
- Matthew J. Leonard
- Director
- 92.83萬
- Muthusamy Shanmugam
- Director, Head of Research and Development and Chief Operating Office, Novitium Operations
- --
- Dr. Renee P. Tannenbaum, D.Pharm.
- Independent Director
- 39.24萬
- Jeanne Thomas
- Independent Director
- 39.58萬
- Thomas J. Haughey
- Independent Director
- 41.22萬
- Antonio R. Pera
- Independent Director
- 39.33萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據